# Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers

> **NCT04570644** · PHASE1 · COMPLETED · sponsor: **AZTherapies, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteers
- Alzheimer Disease

## Interventions

- **DRUG:** ALZT-OP1 (cromolyn and ibuprofen) ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)

## Key facts

- **NCT ID:** NCT04570644
- **Lead sponsor:** AZTherapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-28
- **Primary completion:** 2021-01-18
- **Final completion:** 2021-01-18
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04570644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04570644, "Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04570644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*